The INSPIRE-Lung Study
LungTalk and leveraging Facebook-targeted Advertisement (FBTA) addresses the call to develop and test multi-level, cancer communication interventions using innovative methods and designs. The study's long term goal is to increase lung cancer screening uptake among appropriate, high-risk individuals nationwide.
Checked against the public recordLast updated Nov 21, 2025 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Screening
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Hackensack Meridian Health
- Interventions being studied
- Behavioral: LungTalk; Behavioral: Non-tailored intervention - Standard of practice
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * ≥20-pack-year smoking history; * Individuals who currently smoke or quit smoking within the past 15 years Exclusion Criteria: * Previously undergone LDCT for early detection of lung cancer, have a lung nodule or nodules that are currently being followed * Has ever been diagnosed with lung cancer * Individuals with impaired decision-making (because our primary outcome is decision-making, we will not include individuals with impaired decision-making)
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Hackensack Meridian Health - Center for Discovery and InnovationNutley, New Jersey
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Nov 21, 2025. Always confirm current availability with the study team.